Vitura Health (ASX: VIT) — Company Overview, News & Financial Data
Vitura Health is an Australian medicinal cannabis company focused on the development and education of cannabis products.
Vitura Health
Vitura Health is an Australian healthcare and digital health company that operates a portfolio of digital health platforms, clinical service businesses, and therapeutic distribution networks. The organization connects medical practitioners, pharmacies, patients, and suppliers across Australia through integrated B2B ordering and inventory systems for medicinal cannabis and emerging therapies, alongside consumer-facing telehealth platforms and specialized virtual clinical consultation services.
Snapshot
Operations
Products and/or services of Vitura Health
- Digital B2B Healthcare Marketplace: Enterprise digital platform connecting prescribers, pharmacies, and wholesale distributors to facilitate the compliant ordering, inventory tracking, and nationwide dispatch of medicinal cannabis and restricted therapeutic products across Australia.
- Telehealth and Virtual Care Platforms: Integrated digital health platforms delivering remote medical consultations, electronic prescription generation, and direct patient care services through a national network of registered general practitioners and clinical specialists across Australia.
- Medicinal Cannabis Wholesale Distribution: Specialized pharmaceutical logistics, warehousing, and distribution operations providing nationwide supply chain management for certified medicinal cannabis oils, flower products, capsules, and therapeutic formulations to licensed community pharmacies.
- Direct-to-Patient Digital Health Solutions: Personalized online clinical consultation tools and customized patient care management systems streamlining patient intake assessments, medical treatment plans, electronic prescription fulfillment, and continuous care monitoring for chronic health conditions.
- Psychedelic Therapeutics Supply and Manufacturing: Specialized commercial entity focused on the importation, licensed local GMP manufacturing, and clinical distribution of MDMA and psilocybin formulations for authorized medical prescribers under Australian therapeutic regulations.
- Proprietary Medical Cannabis Product Development: In-house formulation, branding, and commercial distribution of standardized medicinal cannabis product lines including full-spectrum oils, dried flower, and oral sprays supplied through established pharmaceutical distribution channels across Australia.
Vitura Health executive team
- Justin D. JamesChief Executive Officer
- James FrayneChief Financial Officer
- Trudy AdamsExecutive General Manager of Strategy, Technology & Risk
- Deanna JohnsExecutive GM of People & Culture
- Michael SapountzisCompany Secretary
Latest news about Vitura Health
Recent announcements
What Vitura Health (VIT) has told the market, newest first.
- Q1 FY27 Operational UpdatePrice sensitive
Dividend history
Dividends per share paid by Vitura Health , by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026 | A$0.0020 | — | — | A$0.0020 |
| FY2024 | A$0.0100 | — | — | A$0.0100 |
| FY2023 | A$0.0100 | — | — | A$0.0100 |
Key financials
Reported results for Vitura Health , in AUD.
- Market cap
- 11.9M
- Revenue (TTM)
- 131.2M
- P/E ratio
- —
- EPS (diluted, TTM)
- -0.0
- Dividend yield
- —
- Profit margin
- -3.4%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 131.2M | -2M | -4.4M | |
| 124M | 5.2M | 3.3M | |
| 123.9M | 4.9M | 3.5M | |
| 117.3M | 19.9M | 13.8M |